M2GEN and Microsoft have partnered to advance data-driven solutions for the discovery, research, and development of new oncology therapies.
American Cancer Society CEO Karen Knudsen distributed an internal announcement to ACS on Monday morning:
Here is an update on the FDA effort to cull the backlog of what the agency has colorfully dubbed the “dangling indications” of cancer drugs: two indications taken off the market by sponsors; one facing an uncertain future.
A 1990 Nobel Prize in Physiology or Medicine awarded to E. Donnall Thomas for his discoveries in bone marrow transplantation has been put up for sale by his family.
Richard I. Fisher has stepped down from his roles as Fox Chase Cancer Center president and CEO, Fox Chase Cancer Center director, and senior associate dean for cancer programs at the Lewis Katz School of Medicine at Temple University.
Scott Lippman is transitioning from his role as director of Moores Cancer Center at UC San Diego Health to become the associate vice chancellor for cancer research and care, with the goal of formally launching the Precancer Genome Atlas.
Fifty-four organizations involved in health care sent a letter to the Senate leadership, urging confirmation of Robert Califf as FDA commissioner.
The World Health Organization designated Sylvester Comprehensive Cancer Center, a University of Miami institution, as the first WHO Collaborating Centre for Cervical Cancer Elimination.
Tara O. Henderson was named the service line chief of pediatric cancer and blood diseases at the Chicagoland Children’s Health Alliance, a collaboration between University of Chicago Medicine Comer Children’s Hospital, Advocate Children’s Hospital, and Pediatrics at NorthShore University HealthSystem.
Cleveland Clinic Cancer Center announced the following new staff appointments: Paolo Caimi, Kaleena Chilcote and Joel Saltzman
